期刊文献+

金黄色葡萄球菌临床分离株对万古霉素敏感性的监测 被引量:6

Susceptibility of clinical Staphylococcus aureus isolates to vancomycin
下载PDF
导出
摘要 目的检测金黄色葡萄球菌(金葡菌)对万古霉素药物敏感情况,以监控对万古霉素敏感性降低金葡菌[vaneomyein-intermediate Staphylococcus aureus(S.aureus),VISA]或耐万古霉素金葡菌(vancomycin-resistant S.aureus,VRSA)的出现,防止其暴发流行。方法对石家庄市区2家三级甲等医院分离自痰液、支气管肺泡灌洗液等临床标本的55株金葡菌应用苯唑西林纸片和头孢西丁纸片检测是否为耐甲氧西林的金葡菌(methieilin-resistant S.aureus,MRSA);对检出的MRSA,再用胶乳凝集试验检测青霉素结合蛋白2a(PBp-2a)进一步确认。应用Kirb-Bauer纸片法和琼脂稀释法测定万古霉素对55株金葡菌的抑菌环大小和最低抑菌浓度(MIC值),并比较MRSA与对甲氧西林敏感的金葡菌(methieilin-suseeptibility S.aureus,MSSA)的MIC差异。同时对2004~2005年河北医科大学第二医院分离金葡菌的耐药性状况进行了回顾分析。结果55株金葡菌的万古霉素抑菌环直径15~21mm,MIC≤1mg/L,且MRSA与MSSA两组之间差异无统计学意义(P〉0.05)。河北医科大学第二医院2004年、2005年MRSA的检出率分别为56.8%和64.5%。结论石家庄市区医院分离的55株金葡菌中未检出VISA或VRSA,但部分菌株已经接近耐药折点,应密切关注其发展动向;MRSA的耐药机制可能与金葡菌对糖肽类抗生素耐药无直接相关性。 Objective To inspect the emergence of vancomycin-resistant S. aureus (VRSA) or vancomycinintermediate S. aureus(VISA) in Shijiazhuang. And to detect the susceptibility of vancomycin against Staphylococcus aureus(S, aureus) including methicillin-resistant S. aureus(MRSA). Methods Fifty-five S. aureus strains were isolated from clinical specimen,such as sputum,cerebrospinal fluid from two hospitals in Shijiazhuang city. Thirty strains were selected for MRSA by Kirby-Bauer disk diffusion method with oxacillin and cefoxitin out of 55 isolates and identified by latex agglutination test for the detection of penicillin-blinding protein 2a (PBP 2a). Minimal inhibitory concentration (MIC) of vancomycin against S. aureus was determined by agar dilution test. In the meantime,all the S. aureus isolated from the hospital during 2004 to 2005 were analyzed for the distribution and isolated rate of MRSA. Results MRSA and methicillin-sensitive S. aureus were all susceptible to vancomycin with a MIC ≤ 1 mg/L. The zone diameter of vancomycin against all 55 trains was from 15-21 mm. There was no significant difference of MIC between 30 MRSA strains and 25 MSSA strains. The occurrence of MRSA was 56.8% in 2004 and 64.5% in 2005, respectively. Conclusion VISA or VRSA are not found in the strains; however, the zone diameter and MIC value are close to the breakpoint. MRSA might not be related to the mechanism of vancomycin resistance.
出处 《临床荟萃》 CAS 2009年第1期33-36,共4页 Clinical Focus
基金 科技部国家科技基础条件平台工作重点项目(2005DKA21202-6)
关键词 葡萄球菌 金黄色 万古霉素 甲氧西林 药物耐受性 staphylococcus, aureus vancomycin methicillin; drug tolerance
  • 相关文献

参考文献9

  • 1Hiramatsu K, Hanaki H, Ino T, et al. Methicilin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility[J]. J Antimicrob Chemother, 1997,40 (1) : 135- 136.
  • 2Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistant in Staphylococcus aureus[J]. N Engl J Med,1999,340(7) :493-501.
  • 3Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene[J] ,2003,348(14) : 1342-1347.
  • 4马越,陈鸿波,姚蕾,李景云,张力,胡昌勤,金少鸿.耐甲氧西林金黄色葡萄球菌对万古霉素敏感性的变迁[J].中华内科杂志,2002,41(1):31-33. 被引量:41
  • 5任文贵,邹云,王东,闫兴辉,张晓兵,娄俊.耐甲氧西林金黄色葡萄球菌对万古霉素敏感性的监测[J].中华医院感染学杂志,2004,14(8):924-925. 被引量:25
  • 6Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing ( CLSI document M100-S18)[M]. Wayne: Clinical and Laboratory Standards Institute, 2008 : 46-53.
  • 7Kim HB, Lee YS, Kim BS, et al. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea[J]. Microb Drug Resist,2006,12(1) : 33-38.
  • 8俞汝佳,吕晓菊,过孝静,高燕渝.337株金黄色葡萄球菌对替考拉宁等的体外抗菌活性研究[J].中国抗生素杂志,2005,30(5):274-276. 被引量:5
  • 9Hanaki H, Labischinski H, Inaba Y, et al. Increase in glutamine-non-amidated muropeptidas in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50[J]. J Antimicrob Chemother, 1998,42(3) : 315-320.

二级参考文献13

  • 1Jevons MP. "Celbenin" resistant Staphylococcui. Br Med J, 1961, 242: 124-125.
  • 2Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother , 1997, 40:135-136.
  • 3Centres for Disease Contral. Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR Morb Mortal Wkly Rep, 1997,46:765-766.
  • 4Sieradzki K, Roberts RB, Haber SW, et al. The development of vancomycin resistant in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med, 1999, 340: 517-523.
  • 5Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu-3 and Mu-50. J Antimicrob Chemother, 1998, 42: 199-209.
  • 6Hiramatsu K,Hanaki H, Ino T,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility[J]. Antimicrob Chemother,1997,40:135-136.
  • 7陈拯.指导抗菌治疗的实验室试验[A].李影林主编.临床微生物学及检验[M].北京:人民卫生出版社,1990.86.
  • 8Schaison G, Graninger W, Bouza E. Teicoplanln in the treatmem of serious infection [J]. J Chemother. 2000.12(Supp 15):26.
  • 9郑波,李家泰.利福霉素等6种抗菌药物对金葡球菌体外抗菌作用比较研究[J].中国抗生素杂志,2001,26(4):290-291. 被引量:13
  • 10上海市细菌耐药性监测协作组.上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2002,2(1):1-9. 被引量:241

共引文献67

同被引文献54

  • 1梁蓓蓓,王睿.利奈唑胺、去甲万古霉素等抗菌药物对耐甲氧西林金黄色葡萄球菌的抗菌活性[J].中国临床药理学与治疗学,2008,13(9):1044-1047. 被引量:19
  • 2张绍银.260株耐甲氧西林金黄色葡萄球菌耐药性分析[J].浙江预防医学,2005,17(8):34-34. 被引量:9
  • 3Jena Chastre J, Fagon JV. Ventilator-associated pneumonia[J]. Am J Respir Crit Care Med, 2002,165(7) : 867-903.
  • 4Parke AL, Liu PT, Parke DV. Multiple organ dysfunction syndrome[J]. Inflammopharmacology, 2003,11 ( 1 ) : 87-95.
  • 5王丽,马杰,李顺清,肖娟.重症监护病房革兰阴性杆菌耐药性监测[J].中华医院感染学杂志,2007,17(9):1145-1146. 被引量:17
  • 6国家药典委员会.临床用药须知,2005.
  • 7Fortun J;Navas E;Martinez-Beltran J.Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers:cloxacillin versus glycopeptides in combination with gentamicin[J],2001.
  • 8Sung-Han Kim;Kye-Hyung Kim;Hong-Bin Kim.Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia[J],2008(01).
  • 9Baddour LM;Wilson WR;Bayer AS.Infective endocarditis:diagnosis,antimicrobial therapy,and management of complications[J],2005.
  • 10Joseph T Dipiro;Robert L Talbert;Gary C Yee.Pharmacotherapy:a pathophysiologic approach,2005.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部